Physician profile
Michael Dorian Mcbride
NPI 1407826795
$1,487.97
in general payments reported to CMS, 2019-2025
15 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $61.85 · 2021: $361 · 2022: $177 · 2023: $363 · 2024: $158 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $646.71 | 2021-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $242.31 | 2021-2022 | |
| Tris Pharma INC | $155.19 | 2019-2020 | |
| Abbvie INC. | $151.22 | 2023 | |
| Shire North American Group INC | $62.94 | 2019 | |
| Ironshore Pharmaceuticals INC. | $51.61 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $42.56 | 2019-2021 | |
| Pfizer INC. | $23.77 | 2019-2020 | |
| Corium, LLC | $23.18 | 2022-2023 | Azstarys |
| Glaxosmithkline, LLC. | $19.16 | 2023 | Bexsero |
| Sanofi Pasteur INC. | $16.26 | 2021 | |
| Cranial Technologies, INC | $14.39 | 2023 | Doc Band |
| Vertical Pharmaceuticals, LLC | $13.59 | 2019 | |
| Verrica Pharmaceuticals INC. | $13.06 | 2023 | Ycanth |
| Adlon Therapeutics L.P. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.